NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. Additionally, a bipartisan coalition of U.S.

Legislation

Project CBD

NOVEMBER 11, 2023

I have many patients that want to use cannabis, and they who ask me what product should they get? — and this is probably true in Japan, as well — the time allowed for patient visits has gotten smaller and smaller. I teach many patients breathing exercises, simple breath control methods that I find to be very effective.

Medicine

Cannabis Law Report

JUNE 20, 2021

Patient access. I’ve been working hard with some great advocates for patient access in the UK and this position will give me the opportunity to ensure that patients will have access to the high-quality medicines and products they deserve.”.

Supply Chain

The Cannigma

AUGUST 31, 2021

A 2018 research paper in the International Journal of Drug Policy analyzed in-depth interviews carried out with 24 Israeli physicians working in pain medicine, oncology, and family medicine, and found that “physicians discussed contrasting narratives of cananbi, presenting it as both a medicine and non-medicine.”

Education

Cannabis Law Report

OCTOBER 4, 2021

One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions.

Therapy

Veriheal

MARCH 20, 2023

Psilocybin Policies Around the Nation Let’s explore where psilocybin is legal, decriminalized, and on the ballot across U.S. Both Colorado and Oregon allow patients to take psilocybin under the supervision of regulated and licensed “healing centers.” Missouri Rep. Texas This year, Texas Gov.

Clinical Trials

Cannabis Law Report

MARCH 7, 2022

The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines. With mounting questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it is crucial to understand how we have arrived at this situation.

Clinical Trials

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.

Therapy

United Patients Group

JANUARY 8, 2023

In order to get involved in research, you can look up clinical trials in your area that may be accepting volunteers. The post Cannabis and the Immune System appeared first on United Patients Group. The time is ripe for more research on this front, especially as more countries move towards legalizing medical marijuana.

Blood Pressure

Cannabis Law Report

AUGUST 19, 2021

. – ‘No definitive evidence’ – British charity Versus Arthritis recommends patients contemplating CBD should consult their doctor beforehand, and also wants more work done to understand its impact. ” [link].

Cannabinoids

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. Medical marijuana for HIV/AIDS offers a promising complementary treatment for patients.

Patients

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? That’s what most providers are worried about when their patients with PTSD decide to try cannabis.”. Co-author Dr Sue Sisley says that the results are promising.

Clinical Trials

Cannabis Law Report

JUNE 14, 2022

PAREA is a non-profit, multistakeholder and multidisciplinary partnership bringing together patient organizations, medical associations, scientific societies, psychedelic foundations, and the for-profit sector. The good news is that innovations that completely change the lives of patients continue to emerge.

Access

Cannabis Law Report

OCTOBER 10, 2021

As a think tank we develop new ideas and concepts for providing medical cannabis to patients both in Germany and Europe. Cantourage is an innovative company ensuring that patients are able to access the newest medicinal products based on cannabis. YOUR PROFILE: Bachelor’s degree in life science, relevant scientific field required (e.g.

Clinical Trials

Cannabis Law Report

OCTOBER 20, 2021

Critics of the policies point to the U.S. A House subcommittee asked the Department of Veterans Affairs directors why they didn’t support a bipartisan bill ordering the department to conduct clinical trials on the potential benefits of medical marijuana. That will be a big one that the appeals court will need to dive into.”

Hemp

Veriheal

MARCH 23, 2023

Aside from Japan legalizing medical marijuana and forging a legal pathway that enables patients to use drugs made from cannabis plants, the amended legal law also seeks to criminalize the use of marijuana. . ‘1948 Law No.

Legalization

United Patients Group

JANUARY 5, 2023

A 2017 review of 10 clinical trials found that people who took probiotics had a 14% lower risk of contracting a cold or flu. The post 10 Benefits of Probiotics for Your Immune System appeared first on United Patients Group. Probiotics May Reduce Flu Risk. Probiotics may reduce the risk of developing a cold or flu.

Digestion

Cannabis Law Report

NOVEMBER 29, 2019

While the market for medical cannabis is already well developed in some EU member states, only EU-wide standards can ensure patients have the same across Europe. Different legislation across EU countries on prescribing cannabis-based medicines can hinder patients’ access to their treatment when they travel abroad, EUMCA said.

Medicine

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine and profiled on the front page of The New York Times. About MAPS Public Benefit Corporation (MAPS PBC).

Advocacy

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. By contrast, state and local governments are the primary regulators with respect to the creation and enforcement of policies governing to production, use, and sale of alcohol and tobacco. Authors Tracy Gallegos and Neville M.

Business

Project CBD

FEBRUARY 28, 2023

13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinical trials seems to support CBD’s positive effects on nociceptive pain (i.e., Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.

CBD

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.

Law

Cannabis Info

OCTOBER 11, 2019

Now, clinical studies are about to get underway at an Australia university, to track changes in actual dementia patients to see if cannabis can help. In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. Cannabis research in the U.S.

Treatment

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.

Clinical Trials

MMJ Recs

MAY 9, 2024

The proposed legislation seeks to amend existing laws and policies to allow VA healthcare providers to discuss medical marijuana with patients, conduct research on its efficacy, and prescribe medical cannabis in states where it is legal. Any questions related to research can be addressed to VHABLRD-CSRD@va.gov.

Research and Development

Cannabis Law Report

JANUARY 19, 2022

With his extensive experience in Congress and as a policy advisor on topics including health, technology, and education, we are confident Congressman Moran will be a great asset to IGC especially at a time when we pursue Phase 2/3 human trials on IGC- AD1 on individuals that have Alzheimer’s disease.

Clinical Trials

Cannabis Law Report

OCTOBER 17, 2019

(Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Experience in interpretation of regulations, guidelines, policy statements. Key Responsibilities. Position Requirements.

Research and Development

Cannabis Law Report

JULY 13, 2019

clinical trials have been made by Members of Parliament. After months of interviews and weighing-up reams of evidence The House of Commons Health and Social Care Committee has issued its latest report; ‘ Drugs policy: medicinal cannabis’. CBD Testers.co However the problem in the U.K.

Research and Development

MMJ Recs

JULY 5, 2024

The use of THC (Tetrahydrocannabinol) has surged dramatically over the years with an increasing interest in the potential health benefits for medical marijuana patients. Numerous clinical trials are underway to further investigate THC’s efficacy, safety, and potential interactions with other medications as well.

THC

MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. Another influential factor is the growing emphasis on individual autonomy and patient choice in healthcare.

Marijuana

Cannabis Law Report

JULY 15, 2022

“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.

Medicine

Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. .”; “; 4) Article 11 shall be worded as follows: ” Article 11. .”;

Seed-To-Sale

Cannabis Law Report

JULY 15, 2019

Law 33/2018 set the framework for the regulation of the use of cannabis-based medicinal products, preparations and substances that would effectively allow Portuguese patients to access medical cannabis What really has changed during the last year? July 18 marks the first anniversary of the Portuguese medical cannabis law.

Medicine

Cannabis Law Report

JULY 23, 2019

LGC and its investors will benefit from a substantial competitive advantage through their knowledge and clinical trial capacity and its capacity to handle the regulatory compliance process for pharmaceuticals and food products,” said Mazen Haddad, CEO of LGC. Tel: (416) 644-2020 or (514) 939-3989. www.renmarkfinancial.com.

Pharmaceutical

Cannabis Law Report

JUNE 1, 2021

As we prepare for a potential world-class launch of Vicineum, I strongly believe that these leaders will not only bring diverse and invaluable expertise to our team but will also drive the Company to continue executing our mission to save and improve the lives of patients with cancer.”. CAMBRIDGE, Mass.–(BUSINESS

Research and Development